Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Intravenous (IV) Solutions Market
Veterinary Intravenous Solutions Market accounted for USD 1.5 billion in 2023 and is anticipated to experience growth at 8% CAGR between 2024 and 2032. Advancements in veterinary medicine have greatly boosted the market. New IV fluid delivery systems, like specialized infusion pumps and fluid monitors, have made IV solution administration more efficient and safer. These technologies ensure accurate fluid delivery and reduce complications, supporting market growth.
Another key driver is the increase in pet adoption and spending on pet healthcare. As more people adopt pets, the demand for veterinary care, including IV therapy for health issues, surgeries, and critical care, grows. This trend shows a societal shift towards investing more in pet health?.
Veterinary IV solutions are sterile liquids given directly into an animal's bloodstream to treat medical conditions. They help restore hydration, balance electrolytes, and provide nutrients. These solutions are crucial for managing dehydration, shock, and during surgeries. Types include isotonic crystalloids, synthetic colloids, natural colloids, dextrose solutions, and parenteral nutrition. They are vital for maintaining blood volume, tissue perfusion, and supporting metabolic functions in both routine and critical care?.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Veterinary Intravenous Solutions Market Size in 2023: | USD 1.5 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 8% |
2024 – 2032 Value Projection: | USD 3 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 155 |
Tables, Charts & Figures: | 276 |
Segments covered: | Product, Indication, Animal Type, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|